Navigation Links
New Research Shows Many Patients with Persistent Cough and Sputum Actually had Airway Obstruction Consistent with COPD
Date:10/28/2008

on all patients. Albuterol was self-administered for determination of post- bronchodilator FEV(1)/FVC ratio, post-albuterol FEV(1)% of predicted normal and FEV(1) reversibility. All patients had self-reported symptoms of chronic bronchitis and were current or previous cigarette smokers with a history of cigarette smoking of > or = 10 pack-years. COPD was defined as a post- bronchodilator FEV(1)/FVC < or = 0.7.

COPD is characterized by a progressive airflow limitation that is not fully reversible and is associated with an abnormal inflammatory response of the lungs, primarily caused by smoking. The range of conditions described by COPD, which include chronic bronchitis and emphysema, has led to confusion about disease terminology and difficulty with diagnosis especially in the primary care setting. Despite the availability of effective medicines to help manage the disease, many patients with COPD remain undiagnosed and under- treated. This study aimed to characterize airway obstruction, patient characteristics, and patient and provider awareness and understanding of COPD in primary care patients with symptoms of chronic bronchitis.

About the Study

This was a multi-center, cross-sectional study of more than 1,200 subjects 40 years of age and older with a minimum 10 pack-year smoking history and symptoms of chronic bronchitis recruited from primary care centers. There was no treatment intervention in the study. Each study subject completed a single visit encompassing all study procedures, which included two questionnaires completed by each study subject. One questionnaire was a compilation of the medical research council (MRC) dyspnea scale, the 12-item Short Form Health Survey (SF-12, version 2), a modified American Thoracic Society (ATS) respiratory questionnaire, and additional questions about disease and smoking history, work and non-work activities missed due to breathing problems. The other questionnaire, The Lung Function Questionnaire (LFQ
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioTrends Research Group, Inc. Recognized as One of Philadelphias Fastest Growing Privately Held Companies
2. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
3. SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia
4. Calvert Research and Auburn University Announce Joint Venture
5. Anti-Stem-Cell-Research Ad Ignores Facts
6. Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
7. Researchers show how to stamp nanodevices with rubber molds
8. Case Western Reserve University researcher improves LCDs with 3-D nanoimaging process
9. Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting
10. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
11. Food and Beverage Giant Joins Kannapolis Research Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Diego, CA (PRWEB) December 18, 2014 ... a limited time special on Sartorius Biohit products ... Free on mLINE pipettes, Picus Electronic Pipette Trade-in Program, ... by Health and Safety officers around the world. They ... manual pipetting. Other features include:, ,     Full ...
(Date:12/19/2014)... Egenix, Inc. is pleased to announce that ... Board, to succeed Donald Fresne ; Mr. Fresne has ... a member of the Board.  In recognition of the many ... over almost twenty years, the Board designated Mr. Fresne as ... established a Search Committee to find a suitable replacement with ...
(Date:12/19/2014)... , Dec. 18, 2014 Relmada Therapeutics, ... for the treatment of chronic pain, announced the results ... "This was a transformational year in Relmada,s ... future for our company," said Sergio Traversa , ... we have executed on key financial, human resource and ...
(Date:12/17/2014)... Based on the revenues gained ... market is dominated by four major players contributing ... These players include GE Healthcare (U.K.), Siemens AG ... , Full Report Copy at http://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.html ... be attributed to its strong product portfolio, which ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4
... PolyOne Corporation,(NYSE: POL ), a premier ... today that it has entered into an exclusive,license ... owned by Battelle., The global market for ... all production consumed in vinyl-based formulations.,Specialty plasticizers currently ...
... 107% over Second Quarter 2007, EMERYVILLE, Calif., Aug. ... reported its financial results,for the three and six months ... million, or $0.08 per diluted share, for the second ... million, or $0.22 per diluted share, in the,same period ...
... /PRNewswire-FirstCall/ - Atrium Innovations Inc.,(TSX: ATB), a recognized ... endorsed products for the health and,nutrition industries, today ... Pierre Fitzgibbon, will present a company overview,at the ... on,Tuesday, August 12, 2008 at 11 am (eastern ...
Cached Biology Technology:PolyOne Corporation Announces an Exclusive License Agreement with Battelle for Bio-Plasticizer Technology 2Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 2Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 3Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 4Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 5Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 6Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 7Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 8Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 9Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 10
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ... robust – with the clinical data to back it ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has ... in the APAC Region 2015-2019"  report to their ... in this market is advances in technology. With ... upgrade biometric solutions to the latest standard that ...
(Date:12/10/2014)... NEW YORK , Dec. 8, 2014 You,ve ... online banking account but can,t remember your password, site key ... birthday? Who was your first grade teacher? ... launches the app that will finally put an ... PINs – 1U TM . 1U leverages a ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... from HIV and hepatitis is increasing in the United States, ... Now, researchers have shown that nearly 40 percent of surgeries ... positive for a bloodborne germ. , "While these rates are ... in effect for some time to prevent the spread of ...
... for storing genetic codes any more. Since DNA can ... -- scientists have been using it as a nanoscale ... devices. , Now Cornell University researchers have made DNA ... for drug delivery and as containers for chemical reactions. ...
... clone human embryos from eggs that have been matured ... for scientists to create embryonic stem cell lines from ... sperm for infertile couples, the 21st annual conference of ... today (Monday 20 June). , Until now, scientists investigating ...
Cached Biology News:Scalpel-free surgery could reduce risk of HIV and hepatitis exposure for health care workers 2Self-assembled DNA buckyballs for drug delivery 2Self-assembled DNA buckyballs for drug delivery 3Invitrogen Launches i-Path -- A Unique Systems Biology Platform at BIO 2005 2Invitrogen Launches i-Path -- A Unique Systems Biology Platform at BIO 2005 3
Prostaglandin-E2 receptor EP2/EP3 Market Segment: GPCRs...
... - Red, 20X Immunogen ... at 20X concentration for use in ... Quality Assurance ... fluorescence polarization assays. ...
Goat polyclonal to SPFH2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: EDEPLETATKEN, corresponding to C terminal amino acids 328-339 of Human SPFH2 Entrez Gene ID: 11...
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C...
Biology Products: